Sex-differences in alpha-1 antitrypsin deficiency: data from the EARCO registry

Background: Sex and gender influence many aspects of chronic obstructive pulmonary disease (COPD). Limited data are available on this topic in alpha-1 antitrypsin deficiency (AATD). We therefore aimed to investigate sex issues in the EARCO registry, a prospective, international, observational cohort...

Descripción completa

Detalles Bibliográficos
Autores: Ersöz, Hilal, Torres-Durán, María, Turner, Alice M., Tanash, Hanan, García, Carlota Rodríguez, Corsico, Angelo Guido, López-Campos Bodineau, José Luis, Trudzinski, Franziska C.
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2025
País:España
Institución:Universidad de Sevilla (US)
Repositorio:idUS. Depósito de Investigación de la Universidad de Sevilla
OAI Identifier:oai:idus.us.es:11441/180937
Acceso en línea:https://hdl.handle.net/11441/180937
https://doi.org/10.1016/j.arbres.2024.06.019
Access Level:acceso abierto
Palabra clave:Alpha1-antitrypsin
Alpha1-antitrypsin deficiency
Chronic obstructive pulmonary disease
Gender
id ES_be2c0fbacf0d3426f97e4f1f6df09b97
oai_identifier_str oai:idus.us.es:11441/180937
network_acronym_str ES
network_name_str España
repository_id_str
spelling Sex-differences in alpha-1 antitrypsin deficiency: data from the EARCO registryErsöz, HilalTorres-Durán, MaríaTurner, Alice M.Tanash, HananGarcía, Carlota RodríguezCorsico, Angelo GuidoLópez-Campos Bodineau, José LuisTrudzinski, Franziska C.Alpha1-antitrypsinAlpha1-antitrypsin deficiencyChronic obstructive pulmonary diseaseGenderBackground: Sex and gender influence many aspects of chronic obstructive pulmonary disease (COPD). Limited data are available on this topic in alpha-1 antitrypsin deficiency (AATD). We therefore aimed to investigate sex issues in the EARCO registry, a prospective, international, observational cohort study. Methods: Baseline data from PiZZ individuals, enrolled in the registry with complete data on sex and smoking history were analysed by group comparisons and binary logistic regression analyses. Results: 1283 patients with AATD, 49.3% women were analysed. Females reported less tobacco consumption (16.8±12.2 vs. 19.6±14.5 PY, p=0.006), occupational exposures towards gases, dusts or asbestos (p<0.005 each) and consumed less alcohol (5.5±7.6 vs. 8.4±10.3u/week, p<0.001). Females reported COPD (41% vs. 57%, p<0.001) and liver disease (11% vs. 20%, p<0.001) less often. However, they had a higher prevalence of bronchiectasis (24% vs. 13%, p<0.001). Despite better lung function (FEV1%pred. 73.6±29.9 vs. 62.7±29.5, p<0.001) females reported a similar symptom burden (CAT 13.4±9.5 vs. 12.5±8.9, p=ns) and exacerbation frequency (at least one in the previous year 30% vs. 26%, p=ns) compared to males. In multivariate analyses, female sex was an independent risk factor for exacerbations in the previous year OR 1.6 p=0.001 in addition to smoking history, COPD, asthma and bronchiectasis and was also identified as risk factors for symptom burden (CAT≥10) OR 1.4 p=0.014 besides age, BMI, COPD and smoking history. Conclusion: Men had higher rates of COPD and liver disease, women were more likely to have bronchiectasis. Women's higher symptom burden and exacerbation frequency suggest they may need tailored treatment approaches.Elsevier España SLU; Elsevier doyma SLMedicinaInstituto de Biomedicina de Sevilla (IBIS)2025info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttps://hdl.handle.net/11441/180937https://doi.org/10.1016/j.arbres.2024.06.019reponame:idUS. Depósito de Investigación de la Universidad de Sevillainstname:Universidad de Sevilla (US)InglésArchivos de bronconeumologia, 61 (1), 22-30.https://www.sciencedirect.com/science/article/pii/S0300289624002448?via%3Dihubinfo:eu-repo/semantics/openAccessoai:idus.us.es:11441/1809372026-06-17T12:51:07Z
dc.title.none.fl_str_mv Sex-differences in alpha-1 antitrypsin deficiency: data from the EARCO registry
title Sex-differences in alpha-1 antitrypsin deficiency: data from the EARCO registry
spellingShingle Sex-differences in alpha-1 antitrypsin deficiency: data from the EARCO registry
Ersöz, Hilal
Alpha1-antitrypsin
Alpha1-antitrypsin deficiency
Chronic obstructive pulmonary disease
Gender
title_short Sex-differences in alpha-1 antitrypsin deficiency: data from the EARCO registry
title_full Sex-differences in alpha-1 antitrypsin deficiency: data from the EARCO registry
title_fullStr Sex-differences in alpha-1 antitrypsin deficiency: data from the EARCO registry
title_full_unstemmed Sex-differences in alpha-1 antitrypsin deficiency: data from the EARCO registry
title_sort Sex-differences in alpha-1 antitrypsin deficiency: data from the EARCO registry
dc.creator.none.fl_str_mv Ersöz, Hilal
Torres-Durán, María
Turner, Alice M.
Tanash, Hanan
García, Carlota Rodríguez
Corsico, Angelo Guido
López-Campos Bodineau, José Luis
Trudzinski, Franziska C.
author Ersöz, Hilal
author_facet Ersöz, Hilal
Torres-Durán, María
Turner, Alice M.
Tanash, Hanan
García, Carlota Rodríguez
Corsico, Angelo Guido
López-Campos Bodineau, José Luis
Trudzinski, Franziska C.
author_role author
author2 Torres-Durán, María
Turner, Alice M.
Tanash, Hanan
García, Carlota Rodríguez
Corsico, Angelo Guido
López-Campos Bodineau, José Luis
Trudzinski, Franziska C.
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Medicina
Instituto de Biomedicina de Sevilla (IBIS)
dc.subject.none.fl_str_mv Alpha1-antitrypsin
Alpha1-antitrypsin deficiency
Chronic obstructive pulmonary disease
Gender
topic Alpha1-antitrypsin
Alpha1-antitrypsin deficiency
Chronic obstructive pulmonary disease
Gender
description Background: Sex and gender influence many aspects of chronic obstructive pulmonary disease (COPD). Limited data are available on this topic in alpha-1 antitrypsin deficiency (AATD). We therefore aimed to investigate sex issues in the EARCO registry, a prospective, international, observational cohort study. Methods: Baseline data from PiZZ individuals, enrolled in the registry with complete data on sex and smoking history were analysed by group comparisons and binary logistic regression analyses. Results: 1283 patients with AATD, 49.3% women were analysed. Females reported less tobacco consumption (16.8±12.2 vs. 19.6±14.5 PY, p=0.006), occupational exposures towards gases, dusts or asbestos (p<0.005 each) and consumed less alcohol (5.5±7.6 vs. 8.4±10.3u/week, p<0.001). Females reported COPD (41% vs. 57%, p<0.001) and liver disease (11% vs. 20%, p<0.001) less often. However, they had a higher prevalence of bronchiectasis (24% vs. 13%, p<0.001). Despite better lung function (FEV1%pred. 73.6±29.9 vs. 62.7±29.5, p<0.001) females reported a similar symptom burden (CAT 13.4±9.5 vs. 12.5±8.9, p=ns) and exacerbation frequency (at least one in the previous year 30% vs. 26%, p=ns) compared to males. In multivariate analyses, female sex was an independent risk factor for exacerbations in the previous year OR 1.6 p=0.001 in addition to smoking history, COPD, asthma and bronchiectasis and was also identified as risk factors for symptom burden (CAT≥10) OR 1.4 p=0.014 besides age, BMI, COPD and smoking history. Conclusion: Men had higher rates of COPD and liver disease, women were more likely to have bronchiectasis. Women's higher symptom burden and exacerbation frequency suggest they may need tailored treatment approaches.
publishDate 2025
dc.date.none.fl_str_mv 2025
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/11441/180937
https://doi.org/10.1016/j.arbres.2024.06.019
url https://hdl.handle.net/11441/180937
https://doi.org/10.1016/j.arbres.2024.06.019
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Archivos de bronconeumologia, 61 (1), 22-30.
https://www.sciencedirect.com/science/article/pii/S0300289624002448?via%3Dihub
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Elsevier España SLU; Elsevier doyma SL
publisher.none.fl_str_mv Elsevier España SLU; Elsevier doyma SL
dc.source.none.fl_str_mv reponame:idUS. Depósito de Investigación de la Universidad de Sevilla
instname:Universidad de Sevilla (US)
instname_str Universidad de Sevilla (US)
reponame_str idUS. Depósito de Investigación de la Universidad de Sevilla
collection idUS. Depósito de Investigación de la Universidad de Sevilla
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869418263140630528
score 15.811543